Hayfever sufferers rejoice – there’s a new treatment on the way that can reduce all your symptoms for three to six years. That’s according to the scientific journal Immunotherapy, which recently completed a long-term study into Allergy Therapeutics’ (AGY) novel treatment, Pollinex Quattro.
IC TIP:
Buy
at
27p
That’s great news for the company, which is yet to study the impacts of its drug in a large patient population, having spent most of the past five years attempting to find the correct dosage. In May the group completed its dose-ranging trial and will start its final phase of testing during next year’s pollen season.
